- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06232590
Performance Comparison of Two Monthly Replacement Silicone Hydrogel Multifocal Lens Types
January 21, 2025 updated by: CooperVision International Limited (CVIL)
To evaluate and compare the performance of two monthly replacement multifocal contact lenses in existing wearers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This was a prospective, randomized, participant-masked, crossover, bilateral dispensing study.
Each lens type was worn for approximately 4-6 weeks: the lens prescription of each lens type was optimized after 3-10 days wearing experience, prior to starting a 1-month (28-32 days) wear period.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5V 3E7
- Spadina Optometry
-
-
-
-
Minnesota
-
Medina, Minnesota, United States, 55364
- Complete Eye Care of Medina
-
-
New York
-
Vestal, New York, United States, 13850
- Sacco Eye Group
-
-
Ohio
-
Granville, Ohio, United States, 43023
- ProCare Vision Center
-
New Bremen, Ohio, United States, 45869
- New Bremen EyeCare
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Were at least 42 years of age and had full legal capacity to volunteer;
- Had read and signed an information consent letter;
- Self-reported having had a full eye examination in the previous two years;
- Anticipated being able to wear the study lenses for at least 8 hours a day, 5 days a week;
- Were willing and able to follow instructions and maintain the appointment schedule;
Habitually wore spherical multifocal soft contact lenses, for the past 3 months minimum:
- Maximum of 4 participants (out of 12) per site could be habitual wearers of daily disposable lenses,
- Maximum of 4 participants (out of 12) per site could be habitual wearers of Biofinity Multifocal,
- Maximum of 4 participants (out of 12) per site could be habitual wearers of either TOTAL30 Multifocal or AirOptix plus HydraGlyde Multifocal
- Had refractive astigmatism no higher than -0.75DC;
- Is presbyopic and requires a reading addition of at least +0.75D and no more than +2.50D;
- Could be fit and achieve binocular distance vision of at least 20/30 Snellen which participants also deem to be 'acceptable', with the available study lens parameters (Distance sphere +4 to -6; near addition as per study design).
Exclusion Criteria:
- Were participating in any concurrent clinical or research study;
- Had any known active ocular disease and/or infection that contraindicated contact lens wear;
- Had a systemic or ocular condition that in the opinion of the investigator may have affected a study outcome variable;
- Were using any systemic or topical medications that in the opinion of the investigator may have affect contact lens wear or a study outcome variable;
- Had known sensitivity to the diagnostic sodium fluorescein used in the study;
- Self-reported as pregnant, lactating or planning a pregnancy at the time of enrolment;
- Had undergone refractive error surgery or intraocular surgery.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Control Lens, then Test Lens
Participants wore Control Lens for 1 month, then the Test Lens for 1 month
|
Multifocal monthly replacement contact lens for 1 month
Multifocal monthly replacement contact lens for 1 month
|
|
Experimental: Test Lens, then Control Lens
Participants wore the Test Lens for 1 month, then the Control Lens for 1 month
|
Multifocal monthly replacement contact lens for 1 month
Multifocal monthly replacement contact lens for 1 month
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lens Handling for Insertion
Time Frame: 1 month
|
Subjective rating collected in office using a 0-100 scale, where 0=Very difficult and 100=Very easy.
The participant rated the study lens considering a typical day in the last 1 month of wear.
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Gina Wesley, Complete Eye Care of Medina
- Principal Investigator: David Wilkinson, Spadina Optometry
- Principal Investigator: Andrew Sacco, Sacco Eye Group
- Principal Investigator: Katherine Bickle, ProCare Vision Center
- Principal Investigator: Dustin Gardner, New Bremen EyeCare
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 23, 2024
Primary Completion (Actual)
July 9, 2024
Study Completion (Actual)
July 9, 2024
Study Registration Dates
First Submitted
January 22, 2024
First Submitted That Met QC Criteria
January 22, 2024
First Posted (Actual)
January 31, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 21, 2025
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EX-MKTG-153
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.